亿帆医药: 董事、高级管理人员离职管理制度

General Provisions - The company establishes a management system for the resignation of directors and senior management to promote healthy and sustainable development [1] - Applicable personnel include directors (including independent directors), the president, vice presidents, financial officers, board secretaries, and other senior management recognized by the company's articles of association [1] Resignation Circumstances and Procedures - Directors and senior management can resign before their term ends, with the resignation effective upon notification to the company [2] - The company must complete the election of new directors within sixty days of a resignation to ensure compliance with legal and regulatory requirements [2] - Resignation procedures include a handover of responsibilities and an internal audit before leaving [2][3] Responsibilities and Obligations of Resigning Directors and Senior Management - Resigning directors and senior management remain liable for their duties performed during their tenure, and their obligations regarding confidentiality and commitments continue post-resignation [3][4] - The company must pursue accountability for any violations of commitments or actions that harm the company's interests [3][4] Shareholding Management of Resigning Directors and Senior Management - Directors and senior management are prohibited from transferring their shares for six months after resignation [4][5] - There are restrictions on the percentage of shares that can be transferred annually during and after their term [4][5] Accountability Mechanism - The board of directors will review and determine accountability measures for any resigning directors or senior management who fail to fulfill their commitments [6] - Resigning individuals can appeal the accountability decisions within fifteen days of notification [6] Supplementary Provisions - Any matters not covered by this system will follow relevant laws, regulations, and the company's articles of association [6]